Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEKTAR THERAPEUTICS | Chief Legal Officer | Common Stock | 230K | $403K | $1.75 | May 17, 2024 | Direct |
NEKTAR THERAPEUTICS | Chief Legal Officer | Stock Option | 325K | Dec 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKTR | NEKTAR THERAPEUTICS | May 17, 2024 | 1 | -$11K | 4 | May 20, 2024 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Feb 20, 2024 | 1 | -$5.17K | 4 | Feb 22, 2024 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Dec 13, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 17, 2023 | 1 | -$3.52K | 4 | Nov 20, 2023 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 16, 2023 | 1 | -$5.63K | 4 | Aug 17, 2023 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | May 16, 2023 | 1 | -$5.43K | 4 | May 17, 2023 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Feb 16, 2023 | 1 | -$24.8K | 4 | Feb 17, 2023 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 16, 2022 | 1 | -$31K | 4 | Nov 18, 2022 | Chief Legal Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 15, 2022 | 3 | -$15.2K | 4 | Aug 17, 2022 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | May 16, 2022 | 1 | -$12.4K | 4 | May 17, 2022 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | Feb 16, 2022 | 1 | -$40.1K | 4 | Feb 18, 2022 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | Dec 16, 2021 | 2 | $0 | 4 | Dec 20, 2021 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | Nov 15, 2021 | 2 | -$86.4K | 4 | Nov 17, 2021 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | Oct 12, 2021 | 1 | $0 | 4 | Oct 14, 2021 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | Aug 16, 2021 | 1 | -$26.4K | 4 | Aug 18, 2021 | SVP & General Counsel |
NKTR | NEKTAR THERAPEUTICS | May 17, 2021 | 1 | -$35.1K | 4 | May 19, 2021 | SVP & General Counsel |